ANVSAnnovis Bio, Inc.同业对比
Annovis Bio, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANVS本股 | $52M#7 | — | — | — | — | -17.3%#7 | — | — | — | — | -42.1%#7 | — |
| OSTX | $57M#1 | — | — | — | — | -223.7%#12 | — | — | — | — | -32.7%#5 | — |
| BOLD | $55M#2 | — | 0.8x#4 | — | — | 11.0%#3 | — | -88.2%#4 | — | — | 77.4%#1 | — |
| HRTX | $55M#3 | — | 8.0x#9 | 0.4x#1 | 7.4%#4 | -42.9%#9 | -1.6%#1 | -289.5%#8 | — | — | -74.8%#12 | — |
| TLPH | $55M#4 | — | 3.8x#7 | 1946.5x#7 | — | -9.9%#6 | -48157.1%#7 | -99.2%#5 | — | — | -19.8%#3 | — |
| PLRX | $53M#5 | — | 0.4x#1 | — | — | -29.0%#8 | — | 101.6%#1 | — | — | -49.3%#8 | — |
| YARW | $52M#6 | 2.3x#1 | 2.4x#5 | 91.3x#3 | 13.8%#3 | 33.5%#1 | -5219.1%#2 | -120.0%#6 | — | — | 10.5%#2 | — |
| GANX | $51M#8 | — | 4.5x#8 | 925.4x#6 | -58.4%#5 | 1.2%#5 | -33908.5%#5 | -178.5%#7 | — | — | -40.5%#6 | — |
| IBIO | $51M#9 | — | 0.6x#3 | 509.6x#5 | -75.0%#6 | -78.7%#11 | -35141.0%#6 | -38.3%#2 | — | — | -50.3%#9 | — |
| SER | $50M#10 | — | — | 384.9x#4 | 132.1%#2 | -72.2%#10 | -18478.5%#4 | — | — | 5#1 | -59.3%#11 | — |
| HOWL | $49M#11 | — | 3.0x#6 | — | — | 13.7%#2 | — | -373.3%#9 | -229.9%#2 | — | -22.2%#4 | — |
| HYPD | $49M#12 | — | 0.5x#2 | 60.4x#2 | 1318.8%#1 | 9.0%#4 | -5743.5%#3 | -44.5%#3 | -46.8%#1 | — | -51.2%#10 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议